• 1. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 4. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 5. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

8-Bromo-3-fluoro-quinoline (CAS 834884-06-9): A Versatile Building Block in Pharmaceutical and Material Sciences

The 8-bromo-3-fluoro-quinoline (CAS 834884-06-9) represents an important heterocyclic compound that has gained significant attention in modern chemical research. As a halogenated quinoline derivative, this compound serves as a crucial pharmaceutical intermediate and material science building block. Its unique molecular structure, featuring both bromine and fluorine substituents on the quinoline scaffold, offers exceptional reactivity for various synthetic transformations.

Recent trends in medicinal chemistry have shown growing interest in fluorinated heterocycles, with 8-bromo-3-fluoro-quinoline being particularly valuable for drug discovery programs. The presence of both bromo and fluoro groups enables selective cross-coupling reactions, making it a preferred choice for constructing complex molecules. Researchers frequently search for "8-bromo-3-fluoro-quinoline synthesis" and "CAS 834884-06-9 applications," reflecting its importance in contemporary organic synthesis.

The physicochemical properties of 8-bromo-3-fluoro-quinoline contribute to its widespread utility. With a molecular weight of 226.04 g/mol, this pale yellow crystalline solid demonstrates excellent stability under standard conditions. Its halogenated quinoline structure provides two distinct reactive sites for further functionalization, answering the common query about "how to modify 8-bromo-3-fluoro-quinoline" that appears in many research forums.

In pharmaceutical applications, 8-bromo-3-fluoro-quinoline derivatives have shown promise in various therapeutic areas. The compound serves as a precursor for quinoline-based drug candidates, particularly in antimicrobial and anticancer research. Recent publications highlight its use in developing kinase inhibitors and antiviral agents, addressing the growing demand for "new quinoline pharmaceuticals" in medical literature.

The material science field has equally benefited from 8-bromo-3-fluoro-quinoline (CAS 834884-06-9). Its incorporation into organic electronic materials has enabled advancements in OLED technology and molecular sensors. The compound's ability to participate in palladium-catalyzed couplings makes it valuable for creating conjugated polymers, a topic frequently searched as "quinoline-based electronic materials."

Quality control of 8-bromo-3-fluoro-quinoline remains a critical consideration for researchers. Standard analytical methods including HPLC purity testing, 1H/13C NMR characterization, and mass spectrometry ensure batch-to-batch consistency. These procedures answer common laboratory questions about "how to analyze 8-bromo-3-fluoro-quinoline" and "CAS 834884-06-9 specifications."

Environmental and safety aspects of halogenated quinolines have become increasingly important discussion points. While 8-bromo-3-fluoro-quinoline requires standard laboratory precautions, its proper handling and disposal follow established protocols for halogenated organic compounds. These considerations address the rising searches for "green chemistry approaches to quinoline synthesis."

The market for 8-bromo-3-fluoro-quinoline intermediates continues to expand, driven by demand from both pharmaceutical and material science sectors. Current research focuses on developing more efficient synthetic routes to this valuable quinoline building block, responding to inquiries about "cost-effective 8-bromo-3-fluoro-quinoline production."

Future perspectives for CAS 834884-06-9 include its potential in bioconjugation chemistry and catalysis. The compound's dual functionality positions it as a key player in emerging technologies, particularly in the development of targeted drug delivery systems and advanced functional materials.

In conclusion, 8-bromo-3-fluoro-quinoline stands as a multifaceted chemical entity with broad applications across scientific disciplines. Its unique combination of bromine and fluorine substituents on the quinoline core enables diverse chemical transformations, making it indispensable for researchers seeking solutions to "complex heterocycle synthesis" and "functional material design."

• 292636-09-0(7-Bromo-4-fluoro-1H-indole)
• 225366-90-5(3-bromo-7-fluoroquinoline)
• 917251-99-1(8-Bromo-5-fluoroquinoline)
• 927800-38-2(4-Bromo-8-fluoroquinoline)
• 22960-18-5(8-Bromo-6-fluoroquinoline)
• 408355-23-7(7-Bromo-5-fluoro-1H-indole)
• 29263-09-0(7-bromo-4-fluoroindole)
• 220513-46-2(6-Bromo-8-fluoroquinoline)
• 1133115-78-2(5-Bromo-8-fluoroquinoline)
• 1416440-63-5(5-bromo-3-fluoro-quinoline)